To compare the clinical and cost consequences of Gadoxetic Acidenhanced magnetic resonance imaging (PV-MRI) to extracellular contrast mediaenhanced MRI (ECCM-MRI) and Multidetector Computed Tomography (MD-CT) in patients with suspected hepatocellular carcinoma (HCC) in South Korea and Thailand. METHODS: The clinical pathway of patients with suspected HCC from the initial imaging procedure (PV-MRI, ECCM-MRI or MD-CT) to the confirmed treatment decision was presented in an economic decision-tree model. The model compared payer relevant costs of the three diagnostic procedures as first line imaging for suspected HCC and the subsequent costs to reach a confirmed treatment decision. The probabilities and resource consumptions were estimated and validated by clinical experts through a Delphi panel process. Costs for diagnostic and treatment options were derived from published sources. RESULTS: Using PV-MRI as first imaging procedure in patients with suspected HCC evokes total cost of US$ 3,098/ patient in Korea. This is 0.1% higher than the costs for MD-CT (US$ 3,094/patient), but 9.9% lower (US$ 306) than the costs of ECCM-MRI (US$ 3,405/patient). In Thailand, PV-MRI (US$ 702/patient) is the least costly alternative compared to ECCM-MRI (US$ 930/patient) and MDCT (US$ 872/patient) and leads to cost savings of US$ 228 US$and US$ 170, respectively. The higher acquisition cost of PV-MRI are more than compensated by the cost saving achieved through the reduced need for confirmatory imaging procedures and the reduced need for changes in the surgical protocol during resection. CONCLUSIONS: Using PV-MRI compared to ECCM-MRI and MD-CT for the first imaging in patients with suspected HCC leads to relevant cost savings for the statutory health insurance in both countries. The impact on health outcomes (e.g. mortality, quality of life) and total cost needs to be shown in an extended study approach. 
PMD29 COMPARING THE ECONOMIC IMPACT OF PROSTHESIS CHOICE IN UNICOMPARTMENTAL KNEE ARTHROPLASTY PROCEDURES: DEVELOPMENT OF AN ECONOMIC MODEL

OBJECTIVES:
The purpose of this study was to develop an economic impact model to calculate and compare the net present cost of unicompartmental knee prostheses. These implants are used in knee arthroplasty procedures and are one of the key cost drivers of the overall procedural cost. METHODS: A model was developed using revision rates published in the Australian National Joint Replacement Registry, to calculate the economic impact on health care systems. It was assumed that the cost of the primary procedure remained constant regardless of the implant used. Only prostheses reporting more than 1 year follow-up (nϭ14) were included. A sensitivity analysis was performed to examine the influence of varying time horizons and discount rates. RESULTS: From a societal perspective, comparing the predicted number of revisions and net present cost of revisions resulted in substantial differences between implants. The longer the time horizon, the greater the differences reported between implants. The effect of different discount rates was less than the effect of different time horizons. For a one time cohort of 2,500 patients, a time horizon of 5 years, a discount rate of 3.5% and a national reimbursement rate for revision for an unicompartmental knee replacement of 10,000 Euros, the net present cost for a national health care system could be as high as 4,500,000 Euros (all patients treated with the implant with the highest revision rate) or as low as 1,200,000 Euros (all patients treated with the implant with the lowest revision rate). CONCLUSIONS: This model may be utilized by health care systems or payers to evaluate the economic impact of choosing implants with low revision rates. Furthermore, the model allows for evidence-based pricing discussions. This study provides important information, regardless of geography, for health systems and payers to consider when selecting an implant for unicompartmental knee arthroplasty procedures. 
PMD30 SHORT TERM HEALTH-ECONOMIC OUTCOMES OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) IN TYPE 1 DIABETES: A COST COMPARISON ANALYSIS
OBJECTIVES:
Typical cost-effectiveness studies of CSII therapy focus on long-term health-economic outcomes, with little emphasis on immediate clinical and economic benefits which underpin long-term complication-related savings. The objective was therefore to evaluate the short-term health-economic outcomes of CSII versus multiple daily injections (MDI), using best practice modelling methodology with a focus on changes in glycosylated haemoglobin (HbA 1c ), severe hypoglycemic events (SHE), insulin consumption and complication and insulin related (CIR) costs. 
METHODS:
OBJECTIVES:
To analyze cost, surgical time, hospitalization time, bleeding and pain scores postoperatively, regarding patients who underwent thyroidectomy using vessel sealer system or harmonic scalpel technique compared to convencional. METHODS: A retrospective study. Thyroidectomies performed between 2007 and 2010 (n ϭ 460), segmented by conventional or minimally invasive technique, used to vessel sealer system or harmonic scalpel. Were analyzed: sex, age, principal diagnosis, type of procedure (total thyroidectomy with or without lymphadenectomy, thyroidectomy with or without lymphadenectomy). The outcomes analyzed were duration of surgery, hospital stay, need for blood transfusions and pain score. The conclusions were based on a significance level of 5% and statistical analyzes were performed using the software R. RESULTS: The outcome duration of surgery, the use of vessel sealer system resulted in increased duration of surgery about 47 minutes when compared to using the conventional technique (p Ͻ0.001) and the use of harmonic scalpel led to a reduction of the length mean surgery in approximately 32 minutes compared to the conventional technique (p Ͻ0.001). Patients who used vessel sealer system or harmonic scalpel had cost more than in patients with the conventional technique. In relation to the outcome scores of pain and blood transfusion there was no difference between the techniques. CONCLUSIONS: The use of harmonic scalpel was favorable in terms of reducing the duration of surgery, but wasn't observed impact on length of hospital stay and cost of the procedure was significantly higher (28%). Using the vessel sealing system are no results in favorable outcomes assessed and the cost increase was significant compared to the conventional technique. OBJECTIVES: Aortic valve replacement (AVR) the most common heart valve operation, accounts for a majority of all valve surgery performed in the elderly. Miniinvasive aortic valve replacement (MiAVR) has several advantages over full sternotomy, mainly less surgical trauma, decreased blood loss, lower mortality and faster recovery. However, it's also associated with some draw-backs, as an increased technical complexity and higher aortic cross-clamp circulation times (CCTs). Perceval S is a new aortic valve which is implanted without need for suturing and a collapsed profile, thus allowing a significant reduction of cross-clamping times, an independent risk factor for worse outcomes, allowing to expand the pool of operable patients with MiAVR. Aim of this simulation study was to predict costs and outcomes of isolated AVR procedures associated with this new valve in 4 European countries (Italy, France, Germany, and UK), as compared to traditional valve implants, from the cost perspective of the hospital. METHODS: A probabilistic, patient-level simulation model was fully coded in WinBugs, permitting a seamless integration of parameter estimation and outcomes prediction, which was entirely based on the associated CCTs and on the surgical technique (mini-invasive vs. full sternotomy), through published correlations. Unit cost were retrieved from official and literature sources for all countries. Besides the incorporated probabilistic sensitivity analysis, a series of deterministic sensitivity analyses was performed. RESULTS: The model predicts less complications with the use of the Perceval S valve, and savings (valve cost excluded) ranging from slightly less than 6,000 € (Italy) to 6,700 £ (UK), mainly related to a reduction in surgery costs and ICU/hospital bed days. Extensive sensitivity analyses confirm the robustness of such findings. CONCLUSIONS: Reduced costs for the surgical procedure, shorter hospital stay and complications mangament wtih Perceval S offset its increased cost in all analysed countries. 
PMD32 OUTCOMES AND COSTS OF ISOLATED AORTIC VALVE REPLACEMENTS ASSOCIATED WITH THE MINI-INVASIVE IMPLANTATION OF A NEW SUTURELESS AND COLLAPSED VALVE IN ITALY, FRANCE, GERMANY, AND UK
PMD33 THE IMPACT OF THREE DIFFERENT IMAGING STRATEGIES ON SURGERY PLANNING FOR PATIENTS WITH COLORECTAL CANCER LIVER METASTASES
